Tetsuro Sasada

3.2k total citations
49 papers, 1.7k citations indexed

About

Tetsuro Sasada is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Tetsuro Sasada has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 29 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Tetsuro Sasada's work include Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (15 papers). Tetsuro Sasada is often cited by papers focused on Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (15 papers). Tetsuro Sasada collaborates with scholars based in Japan, United States and United Kingdom. Tetsuro Sasada's co-authors include Michiyuki Kanai, Arimichi Takabayashi, Yuka Yoshida, Ellis L. Reinherz, Kyogo Itoh, Akira Yamada, Masanori Noguchi, Maki Touma, Tetsuya Ioji and Yo Mizukami and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Tetsuro Sasada

48 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuro Sasada Japan 18 1.2k 800 434 132 131 49 1.7k
Fernando Aranda Spain 28 1.5k 1.2× 1.3k 1.7× 644 1.5× 149 1.1× 189 1.4× 76 2.5k
Takayuki Ohkuri Japan 22 1.5k 1.2× 976 1.2× 583 1.3× 131 1.0× 106 0.8× 56 2.0k
Matteo Grioni Italy 21 955 0.8× 731 0.9× 707 1.6× 361 2.7× 112 0.9× 28 1.7k
Iñaki Etxeberría Spain 17 1.1k 0.9× 1.1k 1.3× 616 1.4× 171 1.3× 137 1.0× 25 1.9k
Helena Escuin-Ordinas United States 13 1.0k 0.9× 1.4k 1.7× 644 1.5× 175 1.3× 273 2.1× 19 2.1k
Teresa Lozano Spain 20 717 0.6× 481 0.6× 393 0.9× 133 1.0× 75 0.6× 43 1.2k
Layla J. Barkal United States 7 1.0k 0.8× 474 0.6× 587 1.4× 162 1.2× 130 1.0× 11 1.6k
Cristina Puig-Saus United States 13 1.0k 0.8× 1.4k 1.7× 704 1.6× 180 1.4× 247 1.9× 18 2.0k
Veronica Steri United States 17 705 0.6× 827 1.0× 796 1.8× 215 1.6× 205 1.6× 34 1.8k
M. Ángela Aznar Spain 18 1.5k 1.3× 1.5k 1.9× 715 1.6× 201 1.5× 185 1.4× 23 2.5k

Countries citing papers authored by Tetsuro Sasada

Since Specialization
Citations

This map shows the geographic impact of Tetsuro Sasada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuro Sasada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuro Sasada more than expected).

Fields of papers citing papers by Tetsuro Sasada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuro Sasada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuro Sasada. The network helps show where Tetsuro Sasada may publish in the future.

Co-authorship network of co-authors of Tetsuro Sasada

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuro Sasada. A scholar is included among the top collaborators of Tetsuro Sasada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuro Sasada. Tetsuro Sasada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mano, Yasunobu, Yuka Igarashi, KEISUKE KOMORI, et al.. (2025). Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer. Frontiers in Immunology. 16. 1521278–1521278.
2.
Azuma, Koichi, Kenta Murotani, Akihiko Kawahara, et al.. (2024). Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy. Cancer Immunology Immunotherapy. 73(11). 214–214. 1 indexed citations
3.
Kasajima, Rika, Koichi Azuma, Tomoyuki Tagami, et al.. (2024). Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma. Frontiers in Immunology. 15. 1361992–1361992. 3 indexed citations
4.
Nakahara, Yoshiro, Taku Kouro, Satoru Motoyama, et al.. (2024). Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors. Frontiers in Cell and Developmental Biology. 11. 1324898–1324898. 3 indexed citations
5.
Sekihara, Kazumasa, Hidetomo Himuro, Nao Saito, et al.. (2022). Evaluation of X-ray and carbon-ion beam irradiation with chemotherapy for the treatment of cervical adenocarcinoma cells in 2D and 3D cultures. Cancer Cell International. 22(1). 391–391. 9 indexed citations
6.
Yada, Erica, Rika Kasajima, Atsushi Niida, et al.. (2021). Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. Biomedicines. 9(10). 1396–1396. 15 indexed citations
7.
Exley, Mark A., Phillip Friedlander, Nadia Alatrakchi, et al.. (2017). Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial. Clinical Cancer Research. 23(14). 3510–3519. 126 indexed citations
8.
Curry, William T., Matthias Piesche, Tetsuro Sasada, et al.. (2016). Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma. Clinical Cancer Research. 22(12). 2885–2896. 45 indexed citations
9.
Sakamoto, Shinjiro, Masanori Noguchi, Akira Yamada, Kyogo Itoh, & Tetsuro Sasada. (2016). Prospect and progress of personalized peptide vaccinations for advanced cancers. Expert Opinion on Biological Therapy. 16(5). 689–698. 12 indexed citations
11.
Yamada, Teppei, Yasuhiro Terazaki, Shinjiro Sakamoto, et al.. (2014). Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens. International Journal of Oncology. 46(1). 55–62. 10 indexed citations
12.
Yutani, Shigeru, Nobukazu Komatsu, Satoko Matsueda, et al.. (2013). Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients’ Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine. Evidence-based Complementary and Alternative Medicine. 2013. 1–10. 11 indexed citations
13.
Takenaka, Miki, Naoko Seki, Uhi Toh, et al.. (2013). FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis. Molecular and Clinical Oncology. 1(4). 625–632. 114 indexed citations
14.
Hainz, Ursula, Martha Wadleigh, Donna Neuberg, et al.. (2012). Detecting T-cell reactivity to whole cell vaccines. OncoImmunology. 1(7). 1095–1103. 14 indexed citations
15.
Kinoshita, Takashi, Koichi Azuma, Tetsuro Sasada, et al.. (2012). Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia. Oncology Letters. 4(3). 477–482. 42 indexed citations
16.
Zhang, Wandi, Wanyong Zeng, Shelby A. Rogers, et al.. (2010). Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion. Clinical Cancer Research. 16(10). 2729–2739. 30 indexed citations
17.
Sasada, Tetsuro, Hailin Yang, & Ellis L. Reinherz. (2002). CD2 Facilitates Differentiation of CD4 Th Cells Without Affecting Th1/Th2 Polarization. The Journal of Immunology. 168(3). 1113–1122. 14 indexed citations
18.
Fiorini, Emma, Ingo Schmitz, Wilfred E. Marissen, et al.. (2002). Peptide-Induced Negative Selection of Thymocytes Activates Transcription of an NF-ΚB Inhibitor. Molecular Cell. 9(3). 637–648. 90 indexed citations
19.
Sasada, Tetsuro & Ellis L. Reinherz. (2001). A Critical Role for CD2 in Both Thymic Selection Events and Mature T Cell Function. The Journal of Immunology. 166(4). 2394–2403. 39 indexed citations
20.
Sasada, Tetsuro, et al.. (2000). Thymic selection is influenced by subtle structural variation involving the p4 residue of an MHC class I-bound peptide. European Journal of Immunology. 30(5). 1281–1289. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026